Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-024244-15Phase 4Completed
Phase 4, randomised trial of brinzolamide and dorzolamide in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Subject preference for treatment. Started Apr 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-024244-15.